Michael Piccolo
Stock Analyst at Wedbush
(1.24)
# 4,050
Out of 5,182 analysts
9
Total ratings
60%
Success rate
-9.75%
Average return
Main Sectors:
Stocks Rated by Michael Piccolo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TASK TaskUs | Reiterates: Outperform | $14 | $7.42 | +88.68% | 2 | Apr 15, 2026 | |
| STAA STAAR Surgical Company | Maintains: Neutral | $21 → $26 | $25.08 | +3.67% | 2 | Apr 9, 2026 | |
| BUR Burford Capital | Downgrades: Neutral | $6 → $4.75 | $4.96 | -4.23% | 2 | Mar 30, 2026 | |
| CCRN Cross Country Healthcare | Upgrades: Outperform | $11 → $15 | $9.86 | +52.13% | 2 | Mar 19, 2026 | |
| HLLY Holley | Initiates: Outperform | $10 | $3.32 | +201.20% | 1 | Aug 9, 2022 |
TaskUs
Apr 15, 2026
Reiterates: Outperform
Price Target: $14
Current: $7.42
Upside: +88.68%
STAAR Surgical Company
Apr 9, 2026
Maintains: Neutral
Price Target: $21 → $26
Current: $25.08
Upside: +3.67%
Burford Capital
Mar 30, 2026
Downgrades: Neutral
Price Target: $6 → $4.75
Current: $4.96
Upside: -4.23%
Cross Country Healthcare
Mar 19, 2026
Upgrades: Outperform
Price Target: $11 → $15
Current: $9.86
Upside: +52.13%
Holley
Aug 9, 2022
Initiates: Outperform
Price Target: $10
Current: $3.32
Upside: +201.20%